1. Home
  2. PAYO vs HRMY Comparison

PAYO vs HRMY Comparison

Compare PAYO & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Payoneer Global Inc.

PAYO

Payoneer Global Inc.

HOLD

Current Price

$7.11

Market Cap

2.4B

Sector

Technology

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$38.76

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAYO
HRMY
Founded
2005
2017
Country
United States
United States
Employees
2540
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.2B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PAYO
HRMY
Price
$7.11
$38.76
Analyst Decision
Strong Buy
Buy
Analyst Count
8
9
Target Price
$7.69
$44.11
AVG Volume (30 Days)
4.2M
890.3K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.97
EPS
N/A
1.84
Revenue
N/A
$868,453,000.00
Revenue This Year
$7.15
$19.75
Revenue Next Year
$10.28
$12.88
P/E Ratio
$30.36
$21.06
Revenue Growth
N/A
21.51
52 Week Low
$4.08
$25.52
52 Week High
$7.18
$40.87

Technical Indicators

Market Signals
Indicator
PAYO
HRMY
Relative Strength Index (RSI) 62.77 63.35
Support Level $7.07 $37.12
Resistance Level $7.15 $39.07
Average True Range (ATR) 0.04 1.60
MACD -0.04 0.28
Stochastic Oscillator 22.22 82.13

Price Performance

Historical Comparison
PAYO
HRMY

About PAYO Payoneer Global Inc.

Payoneer Global Inc is a financial technology company that enables small and medium-sized businesses (SMBs) to grow internationally through its diversified cross-border payments platform. It connects businesses, professionals, countries, and currencies, reducing the complexity of commerce and enabling customers to pay and get paid as easily as locally. The company offers a financial stack that includes cross-border AR/AP capabilities, funds management, working capital solutions, multicurrency accounts, and workforce management services. Its fully hosted platform provides multiple payment options with minimal integration, along with back-office functions and customer support. The company operates in Israel, the United States, and other countries.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: